Clinical Research Facility
Redondo Beach, California 90277
We've found
7 trials
at this facility
Heart Failure Clinical Trial
Updated: 12/31/1969
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
Updated: 9/30/2015
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling,
Phase
III
Updated: 9/30/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/1/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/1/2015
Click here to add this to my saved trials
Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oral Mucositis Clinical Trial
Updated: 7/6/2016
Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials